Water-in-oil microemulsions for oilfield applications
View Patent ↗A well treatment microemulsion includes an oil external phase, an internal aqueous phase and a hydrophilic surfactant. The surfactant has a hydrophile lipophile balance of between 8-18. The oil external phase may include d-Limonene, xylenes, light mineral oil, or kerosene. The surfactant is configured to emulsify the water of the internal aqueous phase into the oil of the external (continuous) phase. The surfactant may include polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan tristearate, polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan monolaurate or mixtures therebetween. The use of hydrophilic surfactants to emulsify an internal aqueous phase within an oil external microemulsion produces unexpected and beneficial results.
1. A well treatment microemulsion having an internal aqueous phase and an external oil phase, the well treatment microemulsion comprising:
about 35% to about 45% by weight of an oil in the external phase;
about 21% to about 40% by weight of an emulsifying surfactant having a hydrophile lipophile balance of between 10 and 18, wherein the surfactant comprises a surfactant selected from the group consisting of ethoxylated castor oil comprising 25-45 moles of ethylene oxide, ethoxylated alcohols comprising 5-20 moles of ethylene oxide, ethoxylated amides comprising 5-20 moles of ethylene oxide, and ethoxylated fatty acids comprising 5-20 moles of ethylene oxide;
about 1% to about 35% by weight of an alcohol;
and the internal aqueous phase comprises about 9% to about 16% by weight water.
2. The well treatment microemulsion of claim 1 , wherein the oil external phase comprises a hydrocarbon terpene.
3. The well treatment microemulsion of claim 2 , wherein the oil external phase comprises at least one terpene hydrocarbon derived from the group of terpene hydrocarbon sources consisting of citrus, pine, eucalyptus, and peppermint.
4. The well treatment microemulsion of claim 1 , wherein the oil external phase comprises d-limonene.
5. The well treatment microemulsion of claim 1 , wherein the oil external phase comprises at least one component selected from the group consisting of xylenes, parrafin oil, a mixture of cycloparafinic and isoparaffinic oil, and mineral oil.
6. The well treatment microemulsion of claim 1 , wherein the surfactant is selected from the group consisting of ethoxylated alcohols comprising 5-20 moles of ethylene oxide and mixtures of ethoxylated alcohols comprising 5-20 moles of ethylene oxide.
7. The well treatment microemulsion of claim 1 , wherein the surfactant comprises a mixture of polyoxyethylene hydrogenated castor oil and sorbitan monooleate having an average hydrophile lipophile balance of about 10.
8. The well treatment microemulsion of claim 7 , wherein the oil phase comprises between about 35% and 42% by weight d-Limonene, the surfactant comprises between about 30% and 35% by weight a mixture of polyoxyethylene hydrogenated castor oil and sorbitan monooleate and the aqueous phase comprises between about 10% and 15% by weight water.
9. The well treatment microemulsion of claim 1 , wherein the aqueous phase comprises isopropanol.
10. The well treatment microemulsion of claim 1 , wherein the surfactant is selected from the group consisting of polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan tristearate and polyoxyethylene sorbitan monolaurate.
11. The well treatment microemulsion of claim 10 , wherein the oil phase comprises between about 30% and 45% by weight d-limonene, the surfactant comprises between about 30% and 45% by weight sorbitan monostearate and the aqueous phase comprises between about 10% and 15% by weight water.
12. The well treatment microemulsion of claim 11 further comprising isopropanol.
13. The well treatment microemulsion of claim 1 , wherein the oil comprises about 41% to 42% by weight d-limonene, the emulsifying surfactant comprises about 32% to about 33% by weight of polyoxyethylene sorbitan monooleate, the alcohol comprises about 10% to about 12% by weight isopropanol, and the internal aqueous phase comprises about 14% to about 15% by weight water.
14. The well treatment microemulsion of claim 1 , wherein the oil comprises about 35% to 36% by weight d-limonene, the emulsifying surfactant comprises about 20% to about 21% by weight of polyoxyethylene sorbitan monooleate, the alcohol comprises about 33% to about 35% by weight isopropanol, and the internal aqueous phase comprises about 10% by weight water.
15. The well treatment microemulsion of claim 1 , wherein the oil comprises about 41% to 42% by weight hydrocarbon terpenes, the emulsifying surfactant comprises about 32% to about 33% by weight of polyoxyethylene sorbitan monooleate, the alcohol comprises 10% to about 12% by weight isopropanol, and the internal aqueous phase comprises about 14% to about 15% by weight water.
16. The well treatment microemulsion of claim 1 , wherein the oil comprises about 35% to 36% by weight d-limonene, the emulsifying surfactant comprises about 20% to about 21% by weight of polyoxyethylene sorbitan tristearate, the alcohol comprises 33% to about 35% by weight isopropanol, and the internal aqueous phase comprises about 9% to about 10% by weight water.
17. The well treatment microemulsion of claim 1 , wherein the oil comprises about 41% to 42% by weight d-limonene, the emulsifying surfactant comprises about 32% to about 33% by weight of polyoxyethylene sorbitan monooleate, the alcohol comprises about 10% to about 12% by weight isopropanol, and the internal aqueous phase comprises about 14% to about 15% by weight water.
18. The well treatment microemulsion of claim 1 , wherein the surfactant comprises a surfactant selected from the group consisting of ethoxylated castor oil comprising 25-45 moles of ethylene oxide, ethoxylated amides comprising 5-20 moles of ethylene oxide, and ethoxylated fatty acids comprising 5-20 moles of ethylene oxide.